Guangdong Marubi Biotechnology Co. Ltd Financials

Market Capitalization CN¥12.75 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	38.78
Forward PE	27.89
Price to Sales TTM	CN¥4.83
Price to Book MRQ	CN¥3.78
Enterprise to Revenue	4.17
Enterprise to EBITDA	39.69

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	12.28%
Operating Margin	10.18%
Return on Assets TTM	3.90%
Return on Equity TTM	10.14%

Income Statement

Revenue TTM	CN¥2,641,488,640
Revenue per Share TTM	CN¥6.70
Quarterly Revenue Growth	25.80%
Gross Profit TTM	CN¥1,928,844,416
EBITDA	CN¥352,301,850
Net Income to Common TTM	CN¥324,393,056
Diluted EPS TTM	CN¥0.82
Quarterly Earnings Growth YoY	44.30%

Balance Sheet

Total Cash MRQ	CN¥2,098,414,336
Total Cash per Share MRQ	CN¥5.23
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	7.35
Current Ratio MRQ	2.68
Book Value per Share MRQ	CN¥8.42

Cash Flow

Operating Cash Flow TTM	CN¥338,591,168
Levered Free Cash Flow TTM	CN¥115,750,704

603983 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	401,000,000
Float Shares	72,424,610
Avg 10 Volume	1,739,746
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	80.80%
% Held by Institutions	7.59%

Stock Price Summary

Beta	0.21
Fifty Two Week Low	CN¥20.17
Fifty Two Week High	CN¥36.82
Fifty Two Week Change	12.42%
Day 50 MA	CN¥31.71
Day 200 MA	CN¥28.23

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.00
Forward Annual Dividend Yield	3.14%
Trailing Annual Dividend Rate	CN¥0.25
Trailing Annual Dividend Yield	0.79%
Payout Ratio	63.41%
Dividend Date
Ex Dividend Date	2024-11-18
Last Split Factor
Last Split Date